Can you get Ozempic or Wegovy prescribed online in Canada?
What the provincial colleges require of virtual care, who can prescribe, how to check a pharmacy, and the warning signs Health Canada has flagged.
Written for Canada. Reading from India? India version
Yes, if it is done properly. A doctor or nurse practitioner can prescribe a GLP‑1 by video or phone, but provincial colleges say virtual care must meet the same standard as an in-person visit. The medicine must come from a licensed pharmacy, with a DIN on the pack. Ozempic and Mounjaro for weight are off-label.
Key takeaways
- Ontario’s physician college says doctors giving virtual care must meet the same standard of care as in person, “including those pertaining to prescribing drugs”.1
- BC’s college tells physicians to “exercise caution” when prescribing to patients they have not personally examined.2
- In Alberta, about 66% of clinical pharmacists, 4,334 people, held additional prescribing authorization at the end of 2025.3
- Health Canada’s advice is to buy prescription drugs only from a licensed pharmacy and to check the 8-digit DIN on the label.4
- Advertising any drug to the public as a treatment for obesity or diabetes is illegal in Canada, so an ad promising weight loss with a named drug is a red flag.5
- GLP‑1 medicines are prescription drugs in Canada. Nothing here is a reason to start, stop or switch one.6
- We name brands and official prices as facts. We don’t recommend, rank or link to any brand, pharmacy, clinic or program.
- For weight management, Health Canada has approved Wegovy, Zepbound and Saxenda, and the generic Sevmia. Ozempic and Mounjaro are approved for type 2 diabetes.7,6
- Trial results are averages. Some people lose much less, and every benefit comes with risks: see our side effects guide.
On this page
Is it legal to get a GLP‑1 prescribed online?
Yes. Virtual care is allowed, but the provincial colleges hold it to the same standard as an in-person visit.1,2
Ontario’s college says physicians must meet “the standard of care and the existing legal and professional obligations that apply to care that is provided in person, including those pertaining to prescribing drugs”.1
They must also “conduct any assessments, tests, or investigations that are required” to treat you properly.1 BC’s standard adds that physicians should “exercise caution” prescribing for patients they haven’t personally examined.2
Licensing follows the patient. A physician providing virtual care in another province “must comply with the licensing requirements of that jurisdiction”.1,2
Who can prescribe one?
Doctors, including family doctors, and nurse practitioners. In Alberta, many pharmacists can also prescribe.6,3
All GLP‑1 medicines are prescription drugs in Canada.6 No rule we found limits them to specialists.
Alberta pharmacists with additional prescribing authorization (APA) can prescribe “at initial access, for managing ongoing care, or to deprescribe”. About 66% of the province’s clinical pharmacists held it on 31 December 2025.3 We found no specific Alberta guidance on pharmacists starting GLP‑1s for weight.
Approved use matters. For weight, the approved brands are Wegovy, Zepbound, Saxenda and the generic Sevmia; Ozempic and Mounjaro are for type 2 diabetes.7,6
What should an online assessment cover?
Your history, your other medicines, your weight and waist measured properly, pregnancy plans, and a plan for follow-up.1,7,8
- Thyroid history. These medicines are not for anyone with a personal or family history of medullary thyroid cancer, or MEN 2, a rare inherited condition.8
- Other medicines. Insulin or a sulfonylurea raises the risk of low blood sugar, and their doses may need lowering.8
- Your measurements. Canada’s guideline asks prescribers to use waist size and ethnicity-specific BMI cut-offs, not BMI alone.7
- Pregnancy. The guideline advises against these medicines in pregnancy, while breastfeeding or when trying to conceive.7
- Follow-up. The Wegovy label asks for progress to be reassessed after 12 weeks on the maintenance dose.8
If a service skips these, it isn’t meeting the in-person standard. Our guide to choosing a provider has a fuller checklist.
Build your own list before an appointment or an online visit. No sign-up.
How do I check the pharmacy?
Pharmacies are licensed by provinces. Look the pharmacy up on your provincial regulator’s register, and check the DIN on what arrives.9,4
In Ontario, every pharmacy must be licensed by the Ontario College of Pharmacists, which runs a public register.9 Other provinces have their own regulators.
Health Canada says: “Only buy prescription drugs from a licensed pharmacy,” and look for “the eight-digit Drug Identification Number (DIN) on the label”.4 You can look up any DIN in Health Canada’s Drug Product Database.10
We found no national logo scheme for online pharmacies in Canada. The provincial register and the DIN are the checks.
What are the red flags?
Ads promising weight loss with a named drug, no real assessment, “research peptides”, compounded semaglutide, or a product without a DIN.5,11,12,4
- Weight-loss ads naming a drug. The Food and Drugs Act bans advertising any drug to the public as a treatment for obesity or diabetes. Prescription-drug ads may only state the name, price and quantity.5,13
- No prescription needed. Health Canada says injectable “peptides” such as tirzepatide and retatrutide sold online are unauthorized, and “selling unauthorized drugs is illegal in Canada”.11
- A “compounded” version. In June 2025, Health Canada said some pharmacies were compounding it “in the absence of a shortage”, and that outside rare patient-specific cases, making semaglutide this way counts as unlicensed manufacturing.12
- Fake endorsements. Health Canada warns some sellers misuse official logos and show fake endorsements.4
- Shipping from abroad. Residents of Canada generally aren’t allowed to bring prescription drugs into Canada.14
More on fakes: fake and “research peptide” GLP‑1s.
- Stomach effects. About 44 in 100 people on Wegovy 2.4 mg felt sick (nausea), against 16 in 100 on a dummy injection. On Zepbound 15 mg it was about 28 in 100, against about 9 in 100.8,15
- Gallbladder. Gallstones affected about 16 in 1,000 people on Wegovy, against 7 in 1,000 on a dummy injection. An inflamed gallbladder affected about 6 in 1,000 on Zepbound, against 2 in 1,000.8,15
- Pancreatitis (an inflamed pancreas): severe stomach pain that won’t go away, sometimes spreading to the back.8
- Dehydration from vomiting or diarrhea can harm the kidneys.8
- Thyroid and pregnancy. Not for anyone with a personal or family history of medullary thyroid cancer, or MEN 2. Canada’s obesity guideline advises against these medicines in pregnancy, while breastfeeding or when trying to conceive.15,7
Questions people ask
Can I get Ozempic online in Canada?
A licensed prescriber can prescribe it after a virtual assessment that meets the in-person standard. Ozempic is approved for type 2 diabetes; for weight it is off-label.1,17
Is an online GLP-1 prescription valid?
Yes, if it comes from a prescriber licensed where you are and is filled by a licensed pharmacy.2,4
Can a pharmacist prescribe Ozempic?
In Alberta, pharmacists with additional prescribing authorization can prescribe at initial access. We found no specific guidance on GLP‑1s for weight.3
Can I bring GLP-1s in from outside Canada?
Health Canada says residents of Canada are generally not allowed to bring prescription drugs into Canada.14
Why don’t you name online services?
Canadian law restricts advertising prescription drugs and bans advertising them as treatments for obesity or diabetes. We explain the rules and checks, and take no money from any service.5,13
How we researched this
We read the virtual care rules of Ontario’s and BC’s physician colleges, Alberta’s pharmacy college, the Food and Drugs Act and Regulations, and Health Canada’s advisories, all checked on 12 October 2026. We did not check every province’s college one by one.
We don’t name or rate any online service.
Before you move on
- Check the prescriber is licensed in your province.
- Expect questions about your history and medicines.
- Look the pharmacy up on your provincial register.
- Check the DIN on what arrives.
- Walk away from “research peptides” and compounded versions.
More from the Canada blog
The monthly Canada update
An independent guide to GLP‑1 medicines. We don’t sell medicines, take drug-company money, earn commissions or link to any provider. Once a month: Health Canada approvals, recalls, provincial coverage changes and official prices. How we write
Sources
- College of Physicians and Surgeons of Ontario. Virtual Care policy, updated June 2022 (same standard of care, including prescribing; required assessments; licensing). Link
- College of Physicians and Surgeons of British Columbia. Practice Standard: Virtual Care, version 9.3, revised 8 April 2026 (“exercise caution when providing prescriptions … to patients whom they have not personally examined”; licensing in the patient’s jurisdiction). PDF
- Alberta College of Pharmacy. Additional prescribing authorization matters for safe pharmacy practice in Alberta (4,334 of 6,600+ clinical pharmacists, about 66%, held APA on 31 December 2025). 24 February 2026. Link
- Health Canada. Thinking about buying GLP-1 drugs like Ozempic or Mounjaro? Beware of fake or unauthorized products (public advisory: buy only from a licensed pharmacy; check the eight-digit DIN; risks; misused logos and fake endorsements). Updated 21 January 2026. Link
- Food and Drugs Act, R.S.C. 1985, c. F-27: section 2 (“advertisement”), section 3(1) and Schedule A.1 (lists “Diabetes” and “Obesity”). Current to 21 September 2026. Link
- Health Canada. Drug Product Database: status records for every semaglutide product (Ozempic, Rybelsus, Wegovy, Plosbrio, Poviztra; generics from Dr. Reddy’s, Apotex, Aspen and Sandoz, and Sevmia). Searched 12 October 2026. Link
- Pedersen SD, Manjoo P, Dash S, Jain A, Pearce N, Poddar M. Canadian Adult Obesity Clinical Practice Guideline: Pharmacotherapy for Obesity Management in Adults, 2025 update. Obesity Canada, Version 3, 11 August 2025 (recommendations 1–13; six medicines approved for obesity; off-label use discouraged; pregnancy). PDF
- Novo Nordisk Canada. Wegovy (semaglutide injection) Product Monograph, date of authorization 2 October 2026 (indications; dose escalation; STEP 1–3 results and adverse reactions; pancreatitis, gallbladder, kidney and pregnancy warnings; storage). PDF
- Ontario College of Pharmacists. About Find a Pharmacy or Pharmacy Professional (every pharmacy operating in Ontario must be licensed by the College; public register). Checked 12 October 2026. Link
- Health Canada. Drug Product Database search page (search by DIN, product name, company or active ingredient; status “Marketed”, “Approved”, “Cancelled” and others). Checked 12 October 2026. Link
- Health Canada. Unauthorized injectable peptide drugs seized and sold in Canada (more than 40 peptides sold through a company website, including tirzepatide and retatrutide; “Selling unauthorized drugs is illegal in Canada”). Advisory, 1 August 2025. Link
- Health Canada. Health Canada’s position on the unauthorized manufacturing of products sold as compounded GLP-1 receptor agonists. 2 June 2025 (shared by the Ontario College of Pharmacists). Link
- Food and Drug Regulations, C.R.C., c. 870, section C.01.044 (advertising a prescription drug to the public is limited to “the brand name, the proper name, the common name and the price and quantity”). Current to 21 September 2026. Link
- Health Canada. Guidance on the importation of health products for personal use (GUI-0116): “Generally, residents of Canada are not allowed to bring prescription drugs into Canada”. Updated 13 July 2026. Link
- Eli Lilly Canada. Zepbound (tirzepatide injection) Product Monograph, date of authorization 11 June 2026 (indications; “The ZEPBOUND multi-dose KwikPen contains 4 doses”; doses; SURMOUNT-1 and -2 results and adverse reactions; coadministration with Mounjaro not recommended; contraindications). PDF
- Heart and Stroke Foundation of Canada. Medical services by phone (811 in most provinces and Yukon; Info-Santé 811 in Quebec; other numbers in Manitoba, the Northwest Territories and Nunavut). Checked 12 October 2026. Link
- Novo Nordisk Canada. Ozempic (semaglutide injection) Product Monograph, 13 July 2026 (produced by recombinant DNA technology in yeast; 2, 4 and 8 mg pens; indications; adverse reactions table; pancreatitis; contraindications). PDF
Last checked 12 Oct 2026 · Next review due 12 Oct 2027 · Report an error
How this post was made. Written by the GLP Guidebook team from the sources above. It’s general information, not medical advice. Talk to your family doctor, nurse practitioner or pharmacist before starting, stopping or changing any medicine. We don’t sell, prescribe or recommend any brand or provider. How we write